Gallagher Cam - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 31, 2024, Gallagher Cam's relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is Director,Officer (President, Interim CFO), and currently has 633,680 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ZNTL insiders.

Data Source: SEC.
Gallagher Cam - Insider Non-Derivative Transactions of ZNTL Common Stock
Gallagher Cam - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 1, 2024 Sell -- (Common Stock) 9597 11.98 633680
Feb 13, 2024 Sell -- (Common Stock) 1173 11.44 643277
Feb 3, 2024 Sell -- (Common Stock) 11552 11.54 644450
Feb 2, 2024 Acquisition -- (Common Stock) 192500 0 656002
Jun 1, 2023 Sell -- (Common Stock) 18526 26.21 463502
Jun 1, 2023 Sell -- (Common Stock) 9242 26.4 482028
Feb 15, 2023 Sell -- (Common Stock) 8501 19.96 491270
Feb 14, 2023 Sell -- (Common Stock) 3332 20.42 499771
Feb 7, 2023 Sell -- (Common Stock) 572 23.04 503103
Feb 7, 2023 Sell -- (Common Stock) 9428 22.22 503675
Feb 2, 2023 Acquisition -- (Common Stock) 161092 0 513103
Jan 18, 2023 Sell -- (Common Stock) 500 24.87 352011
Jan 18, 2023 Sell -- (Common Stock) 9500 24.11 352511
Jan 6, 2023 Sell -- (Common Stock) 300 21.46 362011
Jan 6, 2023 Sell -- (Common Stock) 9700 21.01 362311